نتایج جستجو برای: cannabinoid receptors

تعداد نتایج: 229376  

Journal: :Current medicinal chemistry 2005
G G Muccioli D M Lambert

Ten years elapsed since the discovery by Sanofi of SR141716A the first selective CB(1) cannabinoid receptor antagonist. Shortly after, Sanofi also reported the synthesis of the first selective CB(2) cannabinoid receptor antagonist, SR144528. Since these two milestones in the cannabinoid field, many other compounds, more or less related to the Sanofi compounds, or based on a completely different...

2016
C. Fede G. Albertin L. Petrelli M.M. Sfriso C. Biz R. De Caro C. Stecco

Cannabinoid receptors have been localized in the central and peripheral nervous system as well as on cells of the immune system, but recent studies on animal tissue gave evidence for the presence of cannabinoid receptors in different types of tissues. Their presence was supposed also in myofascial tissue, suggesting that the endocannabinoid system may help resolve myofascial trigger points and ...

Journal: :Journal of Evolutionary Biology 2006

Ahmadreza Yarabi, Akram Tehranifard, Azam Moshfegh, Katayoon Dastan,

Introduction: There are many similarities between memory impairment in patients suffering from Alzheimer and animals treated by Cannabinoids. The agonists of Cannabinoid receptors affect on a variety of memories and leanings. The present study aims to investigate the role of α-1-adrenergic receptors in central region of amygdala in state-dependent learning induced by WIN55,212-2 (cannabin...

Journal: :Handbook of experimental pharmacology 2005
R G Pertwee

Mammalian tissues express at least two types of cannabinoid receptor, CB1 and CB2, both G protein coupled. CB1 receptors are expressed predominantly at nerve terminals where they mediate inhibition of transmitter release. CB2 receptors are found mainly on immune cells, one of their roles being to modulate cytokine release. Endogenous ligands for these receptors (endocannabinoids) also exist. Th...

Journal: :Brain : a journal of neurology 2011
Cristina Blázquez Anna Chiarlone Onintza Sagredo Tania Aguado M Ruth Pazos Eva Resel Javier Palazuelos Boris Julien María Salazar Christine Börner Cristina Benito Carolina Carrasco María Diez-Zaera Paola Paoletti Miguel Díaz-Hernández Carolina Ruiz Michael Sendtner José J Lucas Justo G de Yébenes Giovanni Marsicano Krisztina Monory Beat Lutz Julián Romero Jordi Alberch Silvia Ginés Jürgen Kraus Javier Fernández-Ruiz Ismael Galve-Roperh Manuel Guzmán

Endocannabinoids act as neuromodulatory and neuroprotective cues by engaging type 1 cannabinoid receptors. These receptors are highly abundant in the basal ganglia and play a pivotal role in the control of motor behaviour. An early downregulation of type 1 cannabinoid receptors has been documented in the basal ganglia of patients with Huntington's disease and animal models. However, the pathoph...

Journal: :Current Biology 2002
Jane M Sullivan

What are endocannabinoids? THC and WIN are examples of exogenous cannabinoid receptor ligands, but the body makes its own ligands, too, and these are referred to as endocannabinoids. Two of the best-characterized endocannabinoids are anandamide and 2-arachidonylglycerol (2AG). Other candidate endocannabinoids have been identified but which, if any, of these compounds are physiologically relevan...

Journal: :Pharmacology, biochemistry, and behavior 2013
Gema Vera Pablo Antonio Cabezos María Isabel Martín Raquel Abalo

Clinical use of antineoplastic drugs is associated with the development of numerous adverse effects that many patients find intolerable, including peripheral neuropathy. Cannabinoids have relieved neuropathic pain in different animal models. But their therapeutic activities could be affected by their psychoactive properties. The aim of this work was to determine the effect of cannabinoids in ci...

2016
Yong Li Jimok Kim

Neurocognitive effects of cannabinoids have been extensively studied with a focus on CB1 cannabinoid receptors because CB1 receptors have been considered the major cannabinoid receptor in the nervous system. However, recent discoveries of CB2 cannabinoid receptors in the brain demand accurate determination of whether and how CB2 receptors are involved in the cognitive effects of cannabinoids. C...

Journal: :Neuroscience 2001
N Hájos C Ledent T F Freund

Psychoactive effects of cannabinoids are thought to be mediated, at least in part, by suppression of both glutamate and GABA release via CB1 cannabinoid receptor. Two types of cannabinoid receptor (CB1 and CB2) have been cloned so far. The CB1 receptors are abundantly expressed in the nervous system, whereas CB2 receptors are limited to lymphoid organs (Matsuda et al., 1990; Munro et al., 1993)...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید